Published on 11/24/2004 in the Prospect News Convertibles Daily.
New Issue: ABN Amro sells $4.9 million 9% reverse exchangeables linked to Boston Scientific
By Caroline Salls
Pittsburgh, Nov. 24 - ABN Amro Bank NV priced $4.9 million of one-year 9% reverse exchangeables linked to Boston Scientific Corp. common stock, according to a 424B3 filing with the Securities and Exchange Commission.
Issuer: | ABN Amro Bank NV
|
Issue: | Reverse exchangeable senior medium-term notes
|
Underlying stock: | Boston Scientific Corp.
|
Amount: | $4.9 million
|
Maturity: | Nov. 23, 2005
|
Coupon: | 9%
|
Price: | Par
|
Payout at maturity: | Smaller of par in cash or 29.394 shares of Boston Scientific stock
|
Exchange ratio: | 29.394
|
Exchange price: | $34.02 (initial level of Boston Scientific stock)
|
Call: | Non-callable
|
Pricing date: | Nov. 19
|
Settlement date: | Nov. 24
|
Lead manager: | ABN Amro Financial Services
|
Distribution: | Off shelf
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.